Old versus new antiepileptic drugs: the SANAD study

Lancet

Volumn 370, Issue 9584, 2007, Pages 314-315

  Shawcross, Debbie ^a   Knighton, Sarah ^a   Bernal, William ^a   Sizer, Elizabeth ^a   Auzinger, Georg ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; VALPROIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; TRIAZINE DERIVATIVE;

ANTICONVULSANT THERAPY; DRUG EFFICACY; DRUG SAFETY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; LETTER; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LYMPHADENOPATHY; MACULOPAPULAR RASH; MALAISE; MONOTHERAPY; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME; ADULT; CLASSIFICATION; EPILEPSY; NOTE; CHEMICALLY INDUCED DISORDER; FEMALE; MORTALITY;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; HUMANS; TRIAZINES; VALPROIC ACID; FEMALE; LIVER FAILURE, ACUTE;

EID: 34447636584     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61152-0     Document Type: Letter

References (5)

1. Marson A., Al Kharusi A., Alwaidh M., et al., on behalf of the SANAD Study Group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369 (2007) 1000-1015
2. Mecarelli O., Pulitano P., Mingoia M., et al. Acute hepatitis associated with lamotrigine and managed with the molecular adsorbents recirculating system (Mars). Epilepsia 46 (2005) 1687-1689
3. Overstreet K., Costanza C., Behling C., Hassanin T., and Masliah E. Fatal progressive hepatic necrosis associated with lamotrigine treatment: a case report and literature review. Dig Dis Sci 47 (2002) 1921-1925
4. Arnon R., DeVivo D., Defelice A., and Kazlow P. Acute hepatic failure in a child treated with lamotrigine. Pediatr Neurol 18 (1998) 251-252
5. Makin A., Fitt S., Williams R., and Duncan J. Fulminant hepatic failure induced by lamotrigine. BMJ 311 (1995) 292